Afrasim Moin
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Molecular Medicine top 2%
Papers in
-
- Drug Solubulity and Delivery Systems 21
- Advanced Drug Delivery Systems 17
- Advancements in Transdermal Drug Delivery 5
- Co-authors
- Syed Mohd Danish Rizvi (42 shared papers)Amr S. Abu Lila (32 shared papers)El‐Sayed Khafagy (21 shared papers)Talib Hussain (28 shared papers)Mohd Adnan (6 shared papers)Mitesh Patel (5 shared papers)Syed Amir Ashraf (5 shared papers)Arif Jamal Siddiqui (4 shared papers)
- Journals
- Pharmaceutics (8 papers)Pharmaceuticals (4 papers)Life (3 papers)Journal of Young Pharmacists (3 papers)Journal of Drug Delivery Science and Technology (3 papers)
- Partner nations
- Saudi ArabiaIndiaEgypt
In The Last Decade
Afrasim Moin
92 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 143
- Pharmaceutical Science 426
- Molecular Medicine 165
- Biomaterials 292
- Applied Microbiology and Biotechnology 33
- Complementary and alternative medicine 108
Countries citing papers authored by Afrasim Moin
This map shows the geographic impact of Afrasim Moin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afrasim Moin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afrasim Moin more than expected).
Fields of papers citing papers by Afrasim Moin
This network shows the impact of papers produced by Afrasim Moin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afrasim Moin. The network helps show where Afrasim Moin may publish in the future.
Co-authors
The 25 scholars most cited alongside Afrasim Moin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 168 | |
| 2 | 2020 | 84 | |
| 3 | 2023 | 80 | |
| 4 | 2016 | 68 | |
| 5 | 2021 | 63 | |
| 6 | 2020 | 58 | |
| 7 | 2020 | 55 | |
| 8 | 2021 | 52 | |
| 9 | 2020 | 51 | |
| 10 | 2015 | 50 | |
| 11 | 2020 | 49 | |
| 12 | 2022 | 48 | |
| 13 | 2022 | 43 | |
| 14 | 2022 | 41 | |
| 15 | 2017 | 41 | |
| 16 | 2012 | 40 | |
| 17 | 2022 | 31 | |
| 18 | 2023 | 30 | |
| 19 | 2018 | 30 | |
| 20 | 2021 | 27 |
About Afrasim Moin
Afrasim Moin is a scholar working on Pharmaceutical Science, Molecular Biology, Food Science, Biomaterials and Materials Chemistry, having authored 103 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (21 papers), Advanced Drug Delivery Systems (17 papers), Polysaccharides Composition and Applications (11 papers), Nanoparticle-Based Drug Delivery (10 papers), Nanoparticles: synthesis and applications (9 papers), Transplantation: Methods and Outcomes (6 papers), Computational Drug Discovery Methods (5 papers) and Advancements in Transdermal Drug Delivery (5 papers). The work is most often cited by research in Pharmaceutical Science (426 citations), Molecular Medicine (165 citations), Biomaterials (292 citations), Applied Microbiology and Biotechnology (33 citations) and Complementary and alternative medicine (108 citations). Afrasim Moin has collaborated with scholars based in Saudi Arabia, India and Egypt. Frequent co-authors include Syed Mohd Danish Rizvi, Amr S. Abu Lila, El‐Sayed Khafagy, Talib Hussain, Mohd Adnan, Mitesh Patel, Syed Amir Ashraf, Arif Jamal Siddiqui, Mejdi Snoussi and H. G. Shivakumar. Their work appears in journals such as Pharmaceutics, Pharmaceuticals, Life, Journal of Young Pharmacists and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.